Atrium Therapeutics RNA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q2 | -1.18 | -22,618 | -20 | |||
| 2026Q1 | -0.97 | -17,280 | -17 | |||
| 2025Q4 | 156.68 | -1.59 | -48,035 | -48 | ||
| 2025Q3 | 108.23 | -1.27 | -188,806 | -174 | ||
| 2025Q2 | 108.79 | -1.21 | -171,142 | -157 | ||
| 2025Q1 | -89.87 | -0.9 | -7,452 | -7 | ||
| 2024Q4 | 173.42 | -0.81 | -44,249 | -46 | ||
| 2024Q3 | 122.06 | -0.64 | -98,133 | -80 | ||
| 2024Q2 | 116.71 | -0.65 | -82,626 | -71 | ||
| 2024Q1 | 112.1 | -0.79 | -77,187 | -69 | ||
| 2023Q4 | 110.42 | -0.8 | -66,743 | -60 | ||
| 2023Q3 | 111.97 | -0.71 | -58,625 | -52 | ||
| 2023Q2 | 111.93 | -0.66 | -52,634 | -47 | ||
| 2023Q1 | 109.93 | -0.74 | -57,596 | -52 | ||
| 2022Q4 | 105.46 | -0.89 | -53,225 | -50 | ||
| 2022Q3 | 103.05 | -0.82 | -44,929 | -44 | ||
| 2022Q2 | 101.33 | -0.92 | -46,299 | -46 | ||
| 2022Q1 | 100.66 | -0.71 | -34,460 | -34 | ||
| 2021Q4 | 100.02 | -0.84 | -38,547 | -39 | ||
| 2021Q3 | 100.02 | -0.67 | -29,280 | -29 |